Not Losing Weight on 1mg Wegovy: What's Actually Going On

Is 1mg actually meant to produce weight loss?

Wegovy's titration schedule runs 0.25mg, 0.5mg, 1mg, 1.7mg, then 2.4mg, each held for roughly four weeks. The lower doses serve one purpose: letting your gastrointestinal system adapt to semaglutide gradually, reducing the nausea and discomfort that hits hardest when the medicine is introduced too quickly.

At 1mg, appetite suppression starts to become noticeable for many people, but the dose is still well below the 2.4mg level where the bulk of clinical evidence sits. So if the scale hasn't shifted much, or at all, that is a normal finding at this point. The NHS medicines guidance on semaglutide confirms that dose escalation continues unless you're struggling with side effects that make it unsafe to go higher.

That said, some people do begin losing weight at 1mg. Biology varies. The question to ask is whether your eating patterns, hydration and activity have genuinely shifted since starting. A useful minute-long check: pull up a typical day's food from last week and count how many meals you skipped or substantially reduced because you simply weren't hungry. If the answer is 'none', the drug may not be suppressing appetite as expected yet, which is worth flagging to your prescriber before the next dose increase, not after. If you found the same issue at the previous step, our guide on not losing weight on 0.5mg Wegovy explains why appetite suppression can be slow to establish in the early doses.

See at what dose most people start losing weight on Wegovy for a fuller picture of where results tend to emerge across the schedule.

Could something else be limiting your response?

Dose timing matters more than people realise. Wegovy works across the full seven-day interval between injections. If injections are being delayed or taken inconsistently, the steady-state exposure that drives appetite suppression is disrupted. Consistent weekly timing, same day each week, is part of how the medicine functions.

Injection technique is another factor that goes unmentioned surprisingly often. Semaglutide is a subcutaneous injection, it needs to reach the fatty layer just beneath the skin, not the muscle, and not be deposited superficially. If the pen isn't being pressed firmly against the skin and held for the full duration, some doses may be incomplete. Rotating sites between the abdomen, outer thigh and upper arm also prevents localised tissue changes that can affect absorption over time.

Separately, a handful of medicines and health conditions can blunt weight-loss response in ways that have nothing to do with semaglutide. Certain antidepressants, corticosteroids, antipsychotics and some antihypertensives are associated with weight retention or gain. Untreated hypothyroidism is a classic one. If you haven't discussed your full medication list and any background conditions with your prescriber recently, now is a reasonable time to do so.

Food choices during treatment also shift the ceiling on results. Semaglutide reduces hunger, but eating calorie-dense foods in smaller volumes can preserve caloric intake almost entirely. Protein adequacy matters too, insufficient protein alongside the reduced appetite common at these doses accelerates muscle loss rather than fat loss, which affects body composition and long-term metabolic rate.

When should you be more concerned about a lack of response?

One to two months of limited progress at 1mg is not a cause for alarm; it's expected. The conversation changes once you've been at the 2.4mg maintenance dose for at least 12 weeks and the scales still haven't moved. What to do when Wegovy at 2.4mg isn't working covers that scenario in detail.

NICE's guidance on semaglutide recommends that treatment is reconsidered if less than 5% weight loss has been achieved after six months on the maintenance dose. That threshold is a clinical marker, not a guarantee of discontinuation, it's a prompt for a prescriber review. Getting to that conversation early, rather than carrying on indefinitely without results, is the right approach.

There is also a separate question of whether Wegovy is the right treatment for you individually. How Wegovy works and who it's prescribed for covers the licensed criteria. For some people, a dual-agonist medicine affects appetite through an additional pathway; your prescriber can discuss whether an alternative would be better suited to your profile.

You can explore the full Wegovy dose schedule if you'd like context on where 1mg sits relative to the rest of the journey, or read about weight-loss expectations at 1.7mg as that's likely your next step.

What actually moves the needle at this stage?

The most reliable thing you can do right now is make the drug's appetite effect work harder by pairing it with a modest, sustainable caloric reduction. You don't need to count calories obsessively, but reducing processed food, increasing protein and fibre, and staying well hydrated reduces the number of calories you'd absorb even on a smaller intake.

Resistance exercise deserves a mention here. At a reduced caloric intake, the body has a tendency to lose muscle alongside fat. Maintaining or building muscle through two to three sessions a week of bodyweight, resistance band or weights-based training helps preserve metabolic rate and improves body composition beyond what the scales alone capture.

Sleep and stress are less glamorous but well-evidenced: consistently poor sleep elevates ghrelin (the hunger hormone) and can partially counteract semaglutide's appetite-suppressing effect. Managing both is part of the clinical picture, not an optional extra.

For an overview of weight management treatment options in the UK, including how Wegovy fits alongside other approaches, that page gives you the wider context. If you have specific questions about your response to treatment so far, the team at our support line is available seven days a week.

When you're ready to talk to a prescriber about your options, speak to our prescribers through a free consultation, no waiting list, reviewed the same day.